These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12183836)

  • 1. Proteolytic enzyme levels are increased during granulocyte colony-stimulating factor-induced hematopoietic stem cell mobilization in human donors but do not predict the number of mobilized stem cells.
    van Os R; van Schie ML; Willemze R; Fibbe WE
    J Hematother Stem Cell Res; 2002 Jun; 11(3):513-21. PubMed ID: 12183836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
    Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2966-70. PubMed ID: 17288807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
    Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
    Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive parameters for granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.
    Okano A; Ashihara E; Shimazaki C; Uchiyama H; Inaba T; Taniguchi K; Maekawa T; Taniwaki M
    J Clin Apher; 2008; 23(6):171-7. PubMed ID: 18988229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flt3 ligand and thrombopoietin serum levels during peripheral blood stem cell mobilization with chemotherapy and recombinant human glycosylated granulocyte colony-stimulating factor (rhu-G-CSF, lenograstim) and after high-dose chemotherapy.
    Bojko P; Pawloski D; Stellberg W; Schröder JK; Seeber S
    Ann Hematol; 2002 Sep; 81(9):522-8. PubMed ID: 12373354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum flt3-ligand in healthy donors undergoing granulocyte colony-stimulating factor-induced peripheral stem cell mobilization.
    Dettke M; Jurko S; Rüger BM; Leitner G; Greinix HT; Kalhs P; Fischer MB; Höcker P
    J Hematother Stem Cell Res; 2001 Apr; 10(2):317-20. PubMed ID: 11359680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HGF/c-Met axis synergizes with G-CSF in the mobilization of hematopoietic stem/progenitor cells.
    Jalili A; Shirvaikar N; Marquez-Curtis LA; Turner AR; Janowska-Wieczorek A
    Stem Cells Dev; 2010 Aug; 19(8):1143-51. PubMed ID: 20021260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in reticulocyte fractions during peripheral stem cell harvesting: role in monitoring stem cell collection.
    Remacha AF; Martino R; Sureda A; Sarda MP; Solá C; Tugues D; Amill B; Garcia J; Oliver A
    Bone Marrow Transplant; 1996 Feb; 17(2):163-8. PubMed ID: 8640161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors.
    Yang SH; Wang TF; Tsai HH; Lin TY; Wen SH; Chen SH
    Transfusion; 2010 May; 50(5):1088-95. PubMed ID: 20051055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.
    Stroncek DF; Clay ME; Petzoldt ML; Smith J; Jaszcz W; Oldham FB; McCullough J
    Transfusion; 1996 Jul; 36(7):601-10. PubMed ID: 8701455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
    Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
    Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosimilar G-CSF versus filgrastim and lenograstim in healthy unrelated volunteer hematopoietic stem cell donors.
    Farhan R; Urbanowska E; Zborowska H; Król M; Król M; Torosian T; Piotrowska I; Bogusz K; Skwierawska K; Wiktor-Jędrzejczak W; Snarski E
    Ann Hematol; 2017 Oct; 96(10):1735-1739. PubMed ID: 28801752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation.
    Kröger N; Renges H; Krüger W; Gutensohn K; Löliger C; Carrero I; Cortes L; Zander AR
    Br J Haematol; 2000 Dec; 111(3):761-5. PubMed ID: 11122135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
    Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor.
    Chen J; Burns KM; Babic A; Carrum G; Kennedy M; Segura FJ; Garcia S; Potts S; Leveque C
    Transfusion; 2014 Jan; 54(1):203-10. PubMed ID: 23763340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors.
    Kröger N; Renges H; Sonnenberg S; Krüger W; Gutensohn K; Dielschneider T; Cortes-Dericks L; Zander AR
    Bone Marrow Transplant; 2002 May; 29(9):727-30. PubMed ID: 12040468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Andersen H; Russell CA; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization.
    Jin F; Zhai Q; Qiu L; Meng H; Zou D; Wang Y; Li Q; Yu Z; Han J; Li Q; Zhou B
    Bone Marrow Transplant; 2008 Nov; 42(9):581-8. PubMed ID: 18679363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.